JP2004520302A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004520302A5 JP2004520302A5 JP2002550771A JP2002550771A JP2004520302A5 JP 2004520302 A5 JP2004520302 A5 JP 2004520302A5 JP 2002550771 A JP2002550771 A JP 2002550771A JP 2002550771 A JP2002550771 A JP 2002550771A JP 2004520302 A5 JP2004520302 A5 JP 2004520302A5
- Authority
- JP
- Japan
- Prior art keywords
- thiosemicarbazide
- carboxyphenyl
- hydroxy
- hydroxybenzylidene
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 27
- 125000000217 alkyl group Chemical group 0.000 claims 20
- 125000003118 aryl group Chemical group 0.000 claims 13
- 239000008194 pharmaceutical composition Substances 0.000 claims 12
- -1 Sulfonyloxy Chemical group 0.000 claims 10
- 229910052739 hydrogen Inorganic materials 0.000 claims 10
- 239000001257 hydrogen Substances 0.000 claims 10
- 150000002431 hydrogen Chemical class 0.000 claims 9
- 150000002148 esters Chemical class 0.000 claims 7
- 150000003839 salts Chemical class 0.000 claims 7
- 239000011780 sodium chloride Substances 0.000 claims 7
- 239000012453 solvate Substances 0.000 claims 7
- 125000000753 cycloalkyl group Chemical group 0.000 claims 6
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 6
- 125000001424 substituent group Chemical group 0.000 claims 6
- 125000000547 substituted alkyl group Chemical group 0.000 claims 5
- FVLKOLRURFXGTB-UHFFFAOYSA-N C1=C(C)C(C)=CC=C1C1=CC=CC(C=NNC(=S)NC=2C=C(C=CC=2)C(O)=O)=C1O Chemical compound C1=C(C)C(C)=CC=C1C1=CC=CC(C=NNC(=S)NC=2C=C(C=CC=2)C(O)=O)=C1O FVLKOLRURFXGTB-UHFFFAOYSA-N 0.000 claims 4
- MWCYXFDINULMKT-UHFFFAOYSA-N C1=CC(C(=O)O)=CC=C1NC(=S)NN=CC1=CC=CC(C=2C=C(C=CC=2)C(F)(F)F)=C1O Chemical compound C1=CC(C(=O)O)=CC=C1NC(=S)NN=CC1=CC=CC(C=2C=C(C=CC=2)C(F)(F)F)=C1O MWCYXFDINULMKT-UHFFFAOYSA-N 0.000 claims 4
- ALKUTHOCHXTHGO-UHFFFAOYSA-N CC1=NN(C=2C=C(Cl)C=CC=2)C(O)=C1C=NNC(=S)NC1=CC=C(C(O)=O)C=C1 Chemical compound CC1=NN(C=2C=C(Cl)C=CC=2)C(O)=C1C=NNC(=S)NC1=CC=C(C(O)=O)C=C1 ALKUTHOCHXTHGO-UHFFFAOYSA-N 0.000 claims 4
- YHBPNJPFCBCOFR-UHFFFAOYSA-N CC1=NN(C=2C=CC(C)=CC=2)C(O)=C1C=NNC(=S)NC1=CC=C(C(O)=O)C=C1 Chemical compound CC1=NN(C=2C=CC(C)=CC=2)C(O)=C1C=NNC(=S)NC1=CC=C(C(O)=O)C=C1 YHBPNJPFCBCOFR-UHFFFAOYSA-N 0.000 claims 4
- WEFMDLQCHTYNBX-UHFFFAOYSA-N CC1=NN(C=2C=CC(C)=CC=2)C(O)=C1C=NNC(=S)NC1=CC=CC(C(O)=O)=C1 Chemical compound CC1=NN(C=2C=CC(C)=CC=2)C(O)=C1C=NNC(=S)NC1=CC=CC(C(O)=O)=C1 WEFMDLQCHTYNBX-UHFFFAOYSA-N 0.000 claims 4
- VFCALJNTDQGHMK-UHFFFAOYSA-N OC(=O)C1=CC=CC(NC(=S)NN=CC=2C(=C(C=CC=2)C=2C=C(C=CC=2)C(F)(F)F)O)=C1 Chemical compound OC(=O)C1=CC=CC(NC(=S)NN=CC=2C(=C(C=CC=2)C=2C=C(C=CC=2)C(F)(F)F)O)=C1 VFCALJNTDQGHMK-UHFFFAOYSA-N 0.000 claims 4
- QIJSYAISKLCJCC-UHFFFAOYSA-N OC(=O)C1=CC=CC(NC(=S)NN=CC=2C(=C(C=CC=2)C=2C=CC(Cl)=CC=2)O)=C1 Chemical compound OC(=O)C1=CC=CC(NC(=S)NN=CC=2C(=C(C=CC=2)C=2C=CC(Cl)=CC=2)O)=C1 QIJSYAISKLCJCC-UHFFFAOYSA-N 0.000 claims 4
- 125000002252 acyl group Chemical group 0.000 claims 4
- 229910052736 halogen Inorganic materials 0.000 claims 4
- 150000002367 halogens Chemical class 0.000 claims 4
- 125000005346 substituted cycloalkyl group Chemical group 0.000 claims 4
- UAWYHCROQVOBQD-UHFFFAOYSA-N C1=C(C)C(C)=CC=C1C1=CC=CC(C=NNC(=S)NC=2C=CC(=CC=2)C(O)=O)=C1O Chemical compound C1=C(C)C(C)=CC=C1C1=CC=CC(C=NNC(=S)NC=2C=CC(=CC=2)C(O)=O)=C1O UAWYHCROQVOBQD-UHFFFAOYSA-N 0.000 claims 3
- WCKCUVQDZQNIGP-UHFFFAOYSA-N C1=CC(C(=O)O)=CC=C1NC(=S)NN=CC1=CC=CC(C=2C3=CC=CC=C3C=CC=2)=C1O Chemical compound C1=CC(C(=O)O)=CC=C1NC(=S)NN=CC1=CC=CC(C=2C3=CC=CC=C3C=CC=2)=C1O WCKCUVQDZQNIGP-UHFFFAOYSA-N 0.000 claims 3
- GBWWYDCAADZYJT-UHFFFAOYSA-N C1=CC(C(=O)O)=CC=C1NC(=S)NN=CC1=CC=CC(C=2C=3C4=CC=CC=C4OC=3C=CC=2)=C1O Chemical compound C1=CC(C(=O)O)=CC=C1NC(=S)NN=CC1=CC=CC(C=2C=3C4=CC=CC=C4OC=3C=CC=2)=C1O GBWWYDCAADZYJT-UHFFFAOYSA-N 0.000 claims 3
- LBMNKCJYSAWRFO-UHFFFAOYSA-N C1=CC(C(=O)O)=CC=C1NC(=S)NN=CC1=CC=CC(C=2C=C(Cl)C=CC=2)=C1O Chemical compound C1=CC(C(=O)O)=CC=C1NC(=S)NN=CC1=CC=CC(C=2C=C(Cl)C=CC=2)=C1O LBMNKCJYSAWRFO-UHFFFAOYSA-N 0.000 claims 3
- WIJLTARCTKJYKH-UHFFFAOYSA-N C1=CC(C(=O)O)=CC=C1NC(=S)NN=CC1=CC=CC(C=2C=CC(F)=CC=2)=C1O Chemical compound C1=CC(C(=O)O)=CC=C1NC(=S)NN=CC1=CC=CC(C=2C=CC(F)=CC=2)=C1O WIJLTARCTKJYKH-UHFFFAOYSA-N 0.000 claims 3
- PYSPXZUPBGJJKO-UHFFFAOYSA-N CC1=NN(C=2C=C(C)C(C)=CC=2)C(O)=C1C=NNC(=S)NC1=CC=C(C(O)=O)C=C1 Chemical compound CC1=NN(C=2C=C(C)C(C)=CC=2)C(O)=C1C=NNC(=S)NC1=CC=C(C(O)=O)C=C1 PYSPXZUPBGJJKO-UHFFFAOYSA-N 0.000 claims 3
- IDSLFZRXTLXFDQ-UHFFFAOYSA-N CC1=NN(C=2C=C(C)C(C)=CC=2)C(O)=C1C=NNC(=S)NC1=CC=CC(C(O)=O)=C1 Chemical compound CC1=NN(C=2C=C(C)C(C)=CC=2)C(O)=C1C=NNC(=S)NC1=CC=CC(C(O)=O)=C1 IDSLFZRXTLXFDQ-UHFFFAOYSA-N 0.000 claims 3
- ZWARMPFQILFHQI-UHFFFAOYSA-N OC(=O)C1=CC=CC(NC(=S)NN=CC=2C(=C(C=CC=2)C=2C3=CC=CC=C3C=CC=2)O)=C1 Chemical compound OC(=O)C1=CC=CC(NC(=S)NN=CC=2C(=C(C=CC=2)C=2C3=CC=CC=C3C=CC=2)O)=C1 ZWARMPFQILFHQI-UHFFFAOYSA-N 0.000 claims 3
- VALRCPIAPNZYED-UHFFFAOYSA-N OC(=O)C1=CC=CC(NC(=S)NN=CC=2C(=C(C=CC=2)C=2C=C(Cl)C=CC=2)O)=C1 Chemical compound OC(=O)C1=CC=CC(NC(=S)NN=CC=2C(=C(C=CC=2)C=2C=C(Cl)C=CC=2)O)=C1 VALRCPIAPNZYED-UHFFFAOYSA-N 0.000 claims 3
- 125000004423 acyloxy group Chemical group 0.000 claims 3
- 125000005037 alkyl phenyl group Chemical group 0.000 claims 3
- 125000004093 cyano group Chemical group *C#N 0.000 claims 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 3
- 125000003107 substituted aryl group Chemical group 0.000 claims 3
- BNYRMVRNPIIDOT-UHFFFAOYSA-N 1-[(2,6-dihydroxy-4-oxocyclohexa-2,5-dien-1-ylidene)methylamino]-3-naphthalen-1-ylthiourea Chemical compound OC1=CC(=O)C=C(O)C1=CNNC(=S)NC1=CC=CC2=CC=CC=C12 BNYRMVRNPIIDOT-UHFFFAOYSA-N 0.000 claims 2
- ISZFHFHMKSHDNL-UHFFFAOYSA-N 1-[(2-hydroxy-4-oxocyclohexa-2,5-dien-1-ylidene)methylamino]-3-naphthalen-1-ylthiourea Chemical compound OC1=CC(=O)C=CC1=CNNC(=S)NC1=CC=CC2=CC=CC=C12 ISZFHFHMKSHDNL-UHFFFAOYSA-N 0.000 claims 2
- LXMBEWGSDLDQMJ-UHFFFAOYSA-N 3-[[(2-oxonaphthalen-1-ylidene)methylamino]carbamothioylamino]benzoic acid Chemical compound OC(=O)C1=CC=CC(NC(=S)NNC=C2C3=CC=CC=C3C=CC2=O)=C1 LXMBEWGSDLDQMJ-UHFFFAOYSA-N 0.000 claims 2
- VXOICBRTBCNFKN-UHFFFAOYSA-N 3-[[[3-(4-chlorophenyl)-2-methoxyphenyl]methylideneamino]carbamothioylamino]benzoic acid Chemical compound C1=CC=C(C=2C=CC(Cl)=CC=2)C(OC)=C1C=NNC(=S)NC1=CC=CC(C(O)=O)=C1 VXOICBRTBCNFKN-UHFFFAOYSA-N 0.000 claims 2
- UDQCKYBBGYUIEG-UHFFFAOYSA-N 3-[[[3-(4-fluorophenyl)-2-methoxyphenyl]methylideneamino]carbamothioylamino]benzoic acid Chemical compound C1=CC=C(C=2C=CC(F)=CC=2)C(OC)=C1C=NNC(=S)NC1=CC=CC(C(O)=O)=C1 UDQCKYBBGYUIEG-UHFFFAOYSA-N 0.000 claims 2
- ZAWWHFNTGMIFMH-UHFFFAOYSA-N 4-[[(2-oxonaphthalen-1-ylidene)methylamino]carbamothioylamino]benzenesulfonic acid Chemical compound C1=CC(S(=O)(=O)O)=CC=C1NC(=S)NNC=C1C2=CC=CC=C2C=CC1=O ZAWWHFNTGMIFMH-UHFFFAOYSA-N 0.000 claims 2
- IQQDCNIEYITSJC-UHFFFAOYSA-N 4-[[(3,5-dibromo-6-oxocyclohexa-2,4-dien-1-ylidene)methylamino]carbamothioylamino]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1NC(=S)NNC=C1C(=O)C(Br)=CC(Br)=C1 IQQDCNIEYITSJC-UHFFFAOYSA-N 0.000 claims 2
- DEMIOKQCDRYZPD-UHFFFAOYSA-N 4-[[(3,5-dichloro-6-oxocyclohexa-2,4-dien-1-ylidene)methylamino]carbamothioylamino]benzenesulfonic acid Chemical compound C1=CC(S(=O)(=O)O)=CC=C1NC(=S)NNC=C1C(=O)C(Cl)=CC(Cl)=C1 DEMIOKQCDRYZPD-UHFFFAOYSA-N 0.000 claims 2
- LMJAWOKRBXTJST-UHFFFAOYSA-N 4-[[(3,5-dichloro-6-oxocyclohexa-2,4-dien-1-ylidene)methylamino]carbamothioylamino]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1NC(=S)NNC=C1C(=O)C(Cl)=CC(Cl)=C1 LMJAWOKRBXTJST-UHFFFAOYSA-N 0.000 claims 2
- XXBOTESYSVDCKG-UHFFFAOYSA-N 4-[[(3-dibenzofuran-1-yl-2-methoxyphenyl)methylideneamino]carbamothioylamino]benzoic acid Chemical compound C1=CC=C(C=2C=3C4=CC=CC=C4OC=3C=CC=2)C(OC)=C1C=NNC(=S)NC1=CC=C(C(O)=O)C=C1 XXBOTESYSVDCKG-UHFFFAOYSA-N 0.000 claims 2
- ZSGJSPQCGKBAQQ-UHFFFAOYSA-N 4-[[2-(naphthalen-1-ylcarbamothioyl)hydrazinyl]methylidene]-3-oxocyclohexa-1,5-diene-1-carboxylic acid Chemical compound C1=CC(C(=O)O)=CC(=O)C1=CNNC(=S)NC1=CC=CC2=CC=CC=C12 ZSGJSPQCGKBAQQ-UHFFFAOYSA-N 0.000 claims 2
- GZOZAGSXKSBOIM-UHFFFAOYSA-N 4-[[[2-methoxy-3-(4-methylphenyl)phenyl]methylideneamino]carbamothioylamino]benzoic acid Chemical compound C1=CC=C(C=2C=CC(C)=CC=2)C(OC)=C1C=NNC(=S)NC1=CC=C(C(O)=O)C=C1 GZOZAGSXKSBOIM-UHFFFAOYSA-N 0.000 claims 2
- URXCYDYNDFNSPK-UHFFFAOYSA-N 4-[[[3-(4-chlorophenyl)-2-methoxyphenyl]methylideneamino]carbamothioylamino]benzoic acid Chemical compound C1=CC=C(C=2C=CC(Cl)=CC=2)C(OC)=C1C=NNC(=S)NC1=CC=C(C(O)=O)C=C1 URXCYDYNDFNSPK-UHFFFAOYSA-N 0.000 claims 2
- OMBHPXMNKZUCQK-UHFFFAOYSA-N C1=C(Cl)C(C)=CC=C1NC(=S)NN=CC1=CC=C(C(O)=O)C=C1O Chemical compound C1=C(Cl)C(C)=CC=C1NC(=S)NN=CC1=CC=C(C(O)=O)C=C1O OMBHPXMNKZUCQK-UHFFFAOYSA-N 0.000 claims 2
- YQXNVEAPRKYUKO-UHFFFAOYSA-N C1=CC(C(=O)O)=CC=C1NC(=S)NN=CC(C(=C1)O)=CC=C1OCC1=CC=CC=C1 Chemical compound C1=CC(C(=O)O)=CC=C1NC(=S)NN=CC(C(=C1)O)=CC=C1OCC1=CC=CC=C1 YQXNVEAPRKYUKO-UHFFFAOYSA-N 0.000 claims 2
- HVQHPDYIFALHFO-UHFFFAOYSA-N C1=CC(C(=O)O)=CC=C1NC(=S)NN=CC1=C(O)C=CC2=CC=CC=C12 Chemical compound C1=CC(C(=O)O)=CC=C1NC(=S)NN=CC1=C(O)C=CC2=CC=CC=C12 HVQHPDYIFALHFO-UHFFFAOYSA-N 0.000 claims 2
- XMXAJWXDVMPTHI-UHFFFAOYSA-N C1=CC(C(=O)O)=CC=C1NC(=S)NN=CC1=CC=C(C=2C=CC=CC=2)C=C1O Chemical compound C1=CC(C(=O)O)=CC=C1NC(=S)NN=CC1=CC=C(C=2C=CC=CC=2)C=C1O XMXAJWXDVMPTHI-UHFFFAOYSA-N 0.000 claims 2
- VTJLRWCGVUSVLQ-UHFFFAOYSA-N C1=CC(C(=O)O)=CC=C1NC(=S)NN=CC1=CC=C(C=CC=C2)C2=C1O Chemical compound C1=CC(C(=O)O)=CC=C1NC(=S)NN=CC1=CC=C(C=CC=C2)C2=C1O VTJLRWCGVUSVLQ-UHFFFAOYSA-N 0.000 claims 2
- ITKPBXHMSPJQOS-UHFFFAOYSA-N C1=CC(C(=O)O)=CC=C1NC(=S)NN=CC1=CC=CC(C=2C=C(C=CC=2)[N+]([O-])=O)=C1O Chemical compound C1=CC(C(=O)O)=CC=C1NC(=S)NN=CC1=CC=CC(C=2C=C(C=CC=2)[N+]([O-])=O)=C1O ITKPBXHMSPJQOS-UHFFFAOYSA-N 0.000 claims 2
- ZYQUZDHIWLYVGE-UHFFFAOYSA-N C1=CC(C)=CC=C1NC(=S)NN=CC1=CC=C(C(O)=O)C=C1O Chemical compound C1=CC(C)=CC=C1NC(=S)NN=CC1=CC=C(C(O)=O)C=C1O ZYQUZDHIWLYVGE-UHFFFAOYSA-N 0.000 claims 2
- CQBBXJRDZBQGOR-UHFFFAOYSA-N C=1C=CC2=CC=CC=C2C=1NC(=S)NN=C(C)C1=CC=C(C(O)=O)C=C1O Chemical compound C=1C=CC2=CC=CC=C2C=1NC(=S)NN=C(C)C1=CC=C(C(O)=O)C=C1O CQBBXJRDZBQGOR-UHFFFAOYSA-N 0.000 claims 2
- ZRSHOJCPIOKLKE-UHFFFAOYSA-N CC(C)(C)C1=CC(C(C)(C)C)=CC(C=NNC(=S)NC=2C=C(C=CC=2)C(O)=O)=C1O Chemical compound CC(C)(C)C1=CC(C(C)(C)C)=CC(C=NNC(=S)NC=2C=C(C=CC=2)C(O)=O)=C1O ZRSHOJCPIOKLKE-UHFFFAOYSA-N 0.000 claims 2
- AKLJHKWOWQKHGD-UHFFFAOYSA-N CC(C)(C)C1=CC(C(C)(C)C)=CC(C=NNC(=S)NC=2C=CC(=CC=2)C(O)=O)=C1O Chemical compound CC(C)(C)C1=CC(C(C)(C)C)=CC(C=NNC(=S)NC=2C=CC(=CC=2)C(O)=O)=C1O AKLJHKWOWQKHGD-UHFFFAOYSA-N 0.000 claims 2
- KRKLVKVKGJPTKL-UHFFFAOYSA-N CC1=C(Cl)C=CC=C1NC(=S)NN=CC1=CC=C(C(O)=O)C=C1O Chemical compound CC1=C(Cl)C=CC=C1NC(=S)NN=CC1=CC=C(C(O)=O)C=C1O KRKLVKVKGJPTKL-UHFFFAOYSA-N 0.000 claims 2
- GECNPSKMOQGWAZ-UHFFFAOYSA-N CC1=CC=C(O)C(C=NNC(=S)NC=2C=C(C=CC=2)C(O)=O)=C1 Chemical compound CC1=CC=C(O)C(C=NNC(=S)NC=2C=C(C=CC=2)C(O)=O)=C1 GECNPSKMOQGWAZ-UHFFFAOYSA-N 0.000 claims 2
- NPJUJWQHRHKWFD-UHFFFAOYSA-N CC1=CC=CC(C=NNC(=S)NC=2C=C(C=CC=2)C(O)=O)=C1O Chemical compound CC1=CC=CC(C=NNC(=S)NC=2C=C(C=CC=2)C(O)=O)=C1O NPJUJWQHRHKWFD-UHFFFAOYSA-N 0.000 claims 2
- UPYSQLCTQXVZNP-UHFFFAOYSA-N CC1=CC=CC(C=NNC(=S)NC=2C=CC(=CC=2)C(O)=O)=C1O Chemical compound CC1=CC=CC(C=NNC(=S)NC=2C=CC(=CC=2)C(O)=O)=C1O UPYSQLCTQXVZNP-UHFFFAOYSA-N 0.000 claims 2
- WSDQJMNLGVQDBD-UHFFFAOYSA-N CC1=CC=CC=C1C1=CC=CC(C=NNC(=S)NC=2C=C(C=CC=2)C(O)=O)=C1O Chemical compound CC1=CC=CC=C1C1=CC=CC(C=NNC(=S)NC=2C=C(C=CC=2)C(O)=O)=C1O WSDQJMNLGVQDBD-UHFFFAOYSA-N 0.000 claims 2
- PLHRTNRUXYEBMB-UHFFFAOYSA-N CC1=CC=CC=C1C1=CC=CC(C=NNC(=S)NC=2C=CC(=CC=2)C(O)=O)=C1O Chemical compound CC1=CC=CC=C1C1=CC=CC(C=NNC(=S)NC=2C=CC(=CC=2)C(O)=O)=C1O PLHRTNRUXYEBMB-UHFFFAOYSA-N 0.000 claims 2
- QNDNPQMXJMDUFD-UHFFFAOYSA-N CC1=NN(C=2C=C(Cl)C=CC=2)C(O)=C1C=NNC(=S)NC1=CC=CC(C(O)=O)=C1 Chemical compound CC1=NN(C=2C=C(Cl)C=CC=2)C(O)=C1C=NNC(=S)NC1=CC=CC(C(O)=O)=C1 QNDNPQMXJMDUFD-UHFFFAOYSA-N 0.000 claims 2
- WCENBRDPMHYUHH-UHFFFAOYSA-N CC1=NN(C=2C=CC(Cl)=CC=2)C(O)=C1C=NNC(=S)NC1=CC=C(C(O)=O)C=C1 Chemical compound CC1=NN(C=2C=CC(Cl)=CC=2)C(O)=C1C=NNC(=S)NC1=CC=C(C(O)=O)C=C1 WCENBRDPMHYUHH-UHFFFAOYSA-N 0.000 claims 2
- LEMGSEFDBUTNLL-UHFFFAOYSA-N CC1=NN(C=2C=CC(Cl)=CC=2)C(O)=C1C=NNC(=S)NC1=CC=CC(C(O)=O)=C1 Chemical compound CC1=NN(C=2C=CC(Cl)=CC=2)C(O)=C1C=NNC(=S)NC1=CC=CC(C(O)=O)=C1 LEMGSEFDBUTNLL-UHFFFAOYSA-N 0.000 claims 2
- SHTIKJUFDWIZFQ-UHFFFAOYSA-N CC1=NN(C=2C=CC=CC=2)C(O)=C1C=NNC(=S)NC1=CC=C(C(O)=O)C=C1 Chemical compound CC1=NN(C=2C=CC=CC=2)C(O)=C1C=NNC(=S)NC1=CC=C(C(O)=O)C=C1 SHTIKJUFDWIZFQ-UHFFFAOYSA-N 0.000 claims 2
- OXCWBKOCWCBSIW-UHFFFAOYSA-N CC1=NN(C=2C=CC=CC=2)C(O)=C1C=NNC(=S)NC1=CC=CC(C(O)=O)=C1 Chemical compound CC1=NN(C=2C=CC=CC=2)C(O)=C1C=NNC(=S)NC1=CC=CC(C(O)=O)=C1 OXCWBKOCWCBSIW-UHFFFAOYSA-N 0.000 claims 2
- TUOFIEPMBWHMFM-UHFFFAOYSA-N OC(=O)C1=CC=CC(C=NNC(=S)NC=2C(=CC=CC=2)C=2C=CC=CC=2)=C1O Chemical compound OC(=O)C1=CC=CC(C=NNC(=S)NC=2C(=CC=CC=2)C=2C=CC=CC=2)=C1O TUOFIEPMBWHMFM-UHFFFAOYSA-N 0.000 claims 2
- GRKPGUWGRCLPRE-UHFFFAOYSA-N OC(=O)C1=CC=CC(NC(=S)NN=CC=2C(=C(Br)C=C(Br)C=2)O)=C1 Chemical compound OC(=O)C1=CC=CC(NC(=S)NN=CC=2C(=C(Br)C=C(Br)C=2)O)=C1 GRKPGUWGRCLPRE-UHFFFAOYSA-N 0.000 claims 2
- VJMQJWOCTBFBPN-UHFFFAOYSA-N OC(=O)C1=CC=CC(NC(=S)NN=CC=2C(=C(C=CC=2)C=2C=3C4=CC=CC=C4OC=3C=CC=2)O)=C1 Chemical compound OC(=O)C1=CC=CC(NC(=S)NN=CC=2C(=C(C=CC=2)C=2C=3C4=CC=CC=C4OC=3C=CC=2)O)=C1 VJMQJWOCTBFBPN-UHFFFAOYSA-N 0.000 claims 2
- PSFGRFWWSASYCL-UHFFFAOYSA-N OC(=O)C1=CC=CC(NC(=S)NN=CC=2C(=C(C=CC=2)C=2C=C(C=CC=2)[N+]([O-])=O)O)=C1 Chemical compound OC(=O)C1=CC=CC(NC(=S)NN=CC=2C(=C(C=CC=2)C=2C=C(C=CC=2)[N+]([O-])=O)O)=C1 PSFGRFWWSASYCL-UHFFFAOYSA-N 0.000 claims 2
- IODNLNAHXFGQHJ-UHFFFAOYSA-N OC(=O)C1=CC=CC(NC(=S)NN=CC=2C(=C(Cl)C=C(Cl)C=2)O)=C1 Chemical compound OC(=O)C1=CC=CC(NC(=S)NN=CC=2C(=C(Cl)C=C(Cl)C=2)O)=C1 IODNLNAHXFGQHJ-UHFFFAOYSA-N 0.000 claims 2
- LQZRVCNWPMJYPJ-UHFFFAOYSA-N OC(=O)C1=CC=CC(NC(=S)NN=CC=2C(=C3C=CC=CC3=CC=2)O)=C1 Chemical compound OC(=O)C1=CC=CC(NC(=S)NN=CC=2C(=C3C=CC=CC3=CC=2)O)=C1 LQZRVCNWPMJYPJ-UHFFFAOYSA-N 0.000 claims 2
- JVOHKSPQGGNUBU-UHFFFAOYSA-N OC(=O)C1=CC=CC(NC(=S)NN=CC=2C(=CC(=CC=2)C=2C=CC=CC=2)O)=C1 Chemical compound OC(=O)C1=CC=CC(NC(=S)NN=CC=2C(=CC(=CC=2)C=2C=CC=CC=2)O)=C1 JVOHKSPQGGNUBU-UHFFFAOYSA-N 0.000 claims 2
- HISAASSZNKFWCP-UHFFFAOYSA-N OC(=O)C1=CC=CC(NC(=S)NN=CC=2C(=CC(OCC=3C=CC=CC=3)=CC=2)O)=C1 Chemical compound OC(=O)C1=CC=CC(NC(=S)NN=CC=2C(=CC(OCC=3C=CC=CC=3)=CC=2)O)=C1 HISAASSZNKFWCP-UHFFFAOYSA-N 0.000 claims 2
- USYCRXALBNDUKJ-UHFFFAOYSA-N OC(=O)C1=CC=CC(NC(=S)NN=CC=2C(=CC=C(Cl)C=2)O)=C1 Chemical compound OC(=O)C1=CC=CC(NC(=S)NN=CC=2C(=CC=C(Cl)C=2)O)=C1 USYCRXALBNDUKJ-UHFFFAOYSA-N 0.000 claims 2
- LUTNFNMHDCINPH-UHFFFAOYSA-N OC1=CC(C(=O)O)=CC=C1C=NNC(=S)NC1=CC=CC=C1C1=CC=CC=C1 Chemical compound OC1=CC(C(=O)O)=CC=C1C=NNC(=S)NC1=CC=CC=C1C1=CC=CC=C1 LUTNFNMHDCINPH-UHFFFAOYSA-N 0.000 claims 2
- 206010043554 Thrombocytopenia Diseases 0.000 claims 2
- 125000004104 aryloxy group Chemical group 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 125000004043 oxo group Chemical group O=* 0.000 claims 2
- 125000005415 substituted alkoxy group Chemical group 0.000 claims 2
- 125000000027 (C1-C10) alkoxy group Chemical group 0.000 claims 1
- OEDUIFSDODUDRK-UHFFFAOYSA-N 5-phenyl-1H-pyrazole Chemical compound N1N=CC=C1C1=CC=CC=C1 OEDUIFSDODUDRK-UHFFFAOYSA-N 0.000 claims 1
- 210000001772 Blood Platelets Anatomy 0.000 claims 1
- FQJSETGPFVXDQM-UHFFFAOYSA-N C1=CC(C(=O)OCC)=CC=C1NC(=S)NN=CC1=CC(Cl)=CC(Cl)=C1O Chemical compound C1=CC(C(=O)OCC)=CC=C1NC(=S)NN=CC1=CC(Cl)=CC(Cl)=C1O FQJSETGPFVXDQM-UHFFFAOYSA-N 0.000 claims 1
- VKHXYYHYCASSEP-UHFFFAOYSA-N CC1=CC(Cl)=CC=C1NC(=S)NN=CC1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1O Chemical compound CC1=CC(Cl)=CC=C1NC(=S)NN=CC1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1O VKHXYYHYCASSEP-UHFFFAOYSA-N 0.000 claims 1
- VFTMCXMWDFLPQM-UHFFFAOYSA-N CC1=CC=CC=C1NC(=S)NN=CC1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1O Chemical compound CC1=CC=CC=C1NC(=S)NN=CC1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1O VFTMCXMWDFLPQM-UHFFFAOYSA-N 0.000 claims 1
- 229920002397 Thermoplastic olefin Polymers 0.000 claims 1
- 125000005354 acylalkyl group Chemical group 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 1
- 125000002102 aryl alkyloxo group Chemical group 0.000 claims 1
- 125000006268 biphenyl-3-yl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C1=C([H])C(*)=C([H])C([H])=C1[H] 0.000 claims 1
- 125000000319 biphenyl-4-yl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims 1
- 125000004663 dialkyl amino group Chemical group 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000002708 enhancing Effects 0.000 claims 1
- 125000001072 heteroaryl group Chemical group 0.000 claims 1
- 150000004677 hydrates Chemical class 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 1
- 125000001624 naphthyl group Chemical group 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 238000007911 parenteral administration Methods 0.000 claims 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N sulfonic acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
Claims (23)
R1は、C1-10アルキル、アリール、ヘテロアリール、ハロゲン、−C(O)OR7、−CONR7R8、−S(O)nR6、−S(O)2NR7R8、スルホニルオキシ、ニトロ、置換されていてもよいアミノ、ヒドロキシ、アルコキシから選択される1個またはそれ以上の置換基で置換されていてもよいアリールであり;
R2は、水素、C1-12アルキル、アリール、置換アリール、ならびに、アルコキシ、アシルオキシ、アリール、置換アリール、アミノ、N−アシルアミノ、オキソ、ヒドロキシ、シクロアルキル、置換シクロアルキル、−C(O)OR7、−S(O)2NR7R8、−S(O)nR6、アリールオキシ、ニトロ、シアノ、ハロゲンおよび保護−OHからなる群から選択される1個またはそれ以上の置換基で置換されているアルキルから選択され、ここで、
R6は、水素、アルキル、シクロアルキル、C1−C12アリール、置換アルキル、置換シクロアルキルおよび置換C1−C12アリールから選択され、
R7およびR8は、独立して、水素、シクロアルキル、アリール、置換シクロアルキル、置換アリール、アルキル、または、アルコキシ、アシルオキシ、アリールオキシ、アミノ、N−アシルアミノ、オキソ、ヒドロキシ、−C(O)OR6、−S(O)nR6、−C(O)NR6R6、−S(O)2NR6R6、ニトロ、シアノ、シクロアルキル、置換シクロアルキル、ハロゲン、C1−C12アリール、置換C1−C12アリールおよび保護−OHからなる群から選択される1個またはそれ以上の置換基で置換されているアルキルから選択され(ここで、R6は上記定義と同じである);
nは、0〜3であり;
Zは、SまたはNR2から選択され(ここで、R2は上記定義と同じである);
R3は、水素、C1−C10アルキル、フェニル、置換フェニル、カルボキシルまたはC1−C10アルコキシカルボニルから選択され;
Lは、ナフチル、または式(L):
R14は、ヒドロキシ、C1−C10アルキル、フェニル、アミノ、モノ−またはジアルキルアミノから選択され、
R12およびR13は、独立して、水素、C1-10アルキル、C1−C12アリール、置換C1−C12アリール、C1-10アシルまたはシクロアルキルから選択される)か;または
A=BまたはD=Eのいずれかは、O、SまたはNR12を表す(ここで、R12は上記定義と同じである))
で示される基であり;
Yは、−S、−Oおよび−NR15から選択され、ここで、R15は、水素、C1−C10アルキル、置換C1−C10アルキル、C1−C6アルキルフェニル、置換C1−C6アルキルフェニル、C1−C10アシル、置換C1−C10アシル、またはSO2R9から選択され、ここで、R9は、C1−C10アルキル、置換C1−C10アルキル、C1−C12アリールまたは置換C1−C12アリールであり;
Xは、−SR16、−OR16または−NHR17から選択され、ここで、R16は、水素、C1−C10アルキルまたは置換C1−C10アルキルであり、
R17は、水素、C1−C10アルキル、置換C1−C10アルキル、C1−C6アルキルフェニル、C1−C10アシルまたは置換C1−C10アシルである]
で示される化合物またはその医薬上許容される塩、水和物、溶媒和物もしくはエステルを含む、血小板減少症を治療するための医薬組成物。 Formula (I):
R 1 is C 1-10 alkyl, aryl, heteroaryl, halogen, —C (O) OR 7 , —CONR 7 R 8 , —S (O) n R 6 , —S (O) 2 NR 7 R 8. , Sulfonyloxy, nitro, aryl optionally substituted with one or more substituents selected from optionally substituted amino, hydroxy, alkoxy;
R 2 is hydrogen, C 1-12 alkyl, aryl, substituted aryl, and alkoxy, acyloxy, aryl, substituted aryl, amino, N-acylamino, oxo, hydroxy, cycloalkyl, substituted cycloalkyl, —C (O) oR 7, -S (O) 2 NR 7 R 8, -S (O) n R 6, aryloxy, nitro, cyano, one or more substituents selected from the group consisting of halogen and protected -OH Selected from alkyl substituted with
R 6 is selected from hydrogen, alkyl, cycloalkyl, C 1 -C 12 aryl, substituted alkyl, substituted cycloalkyl and substituted C 1 -C 12 aryl;
R 7 and R 8 are independently hydrogen, cycloalkyl, aryl, substituted cycloalkyl, substituted aryl, alkyl, or alkoxy, acyloxy, aryloxy, amino, N-acylamino, oxo, hydroxy, —C (O ) OR 6 , —S (O) n R 6 , —C (O) NR 6 R 6 , —S (O) 2 NR 6 R 6 , nitro, cyano, cycloalkyl, substituted cycloalkyl, halogen, C 1 — Selected from alkyl substituted with one or more substituents selected from the group consisting of C 12 aryl, substituted C 1 -C 12 aryl and protected —OH, wherein R 6 is as defined above );
n is 0-3;
Z is selected from S or NR 2 (where R 2 is as defined above);
R 3 is selected from hydrogen, C 1 -C 10 alkyl, phenyl, substituted phenyl, carboxyl or C 1 -C 10 alkoxycarbonyl;
L is naphthyl or formula (L):
R 14 is selected from hydroxy, C 1 -C 10 alkyl, phenyl, amino, mono- or dialkylamino;
R 12 and R 13 are independently selected from hydrogen, C 1-10 alkyl, C 1 -C 12 aryl, substituted C 1 -C 12 aryl, C 1-10 acyl or cycloalkyl); or Either A = B or D = E represents O, S or NR 12 (where R 12 is as defined above))
A group represented by:
Y is selected from —S, —O and —NR 15 , where R 15 is hydrogen, C 1 -C 10 alkyl, substituted C 1 -C 10 alkyl, C 1 -C 6 alkylphenyl, substituted C 1 -C 6 alkylphenyl, C 1 -C 10 acyl is selected from substituted C 1 -C 10 acyl or SO 2 R 9,, wherein, R 9 is, C 1 -C 10 alkyl, substituted C 1 -C 10 alkyl, C 1 -C 12 aryl or substituted C 1 -C 12 aryl;
X is selected from —SR 16 , —OR 16 or —NHR 17 , wherein R 16 is hydrogen, C 1 -C 10 alkyl or substituted C 1 -C 10 alkyl;
R 17 is hydrogen, C 1 -C 10 alkyl, substituted C 1 -C 10 alkyl, C 1 -C 6 alkylphenyl, C 1 -C 10 acyl or substituted C 1 -C 10 acyl]
Or a pharmaceutically acceptable salt, hydrate, solvate or ester thereof, a pharmaceutical composition for treating thrombocytopenia .
Z、R2、R3、L、XおよびYが請求項1における定義と同じである、式(I)で示される化合物またはその医薬上許容される塩、水和物、溶媒和物もしくはエステルを含む、請求項1記載の医薬組成物。 R 1 is phenyl substituted with either carboxylic acid or sulfonic acid;
A compound of formula (I) or a pharmaceutically acceptable salt, hydrate, solvate or ester thereof, wherein Z, R 2 , R 3 , L, X and Y are as defined in claim 1 The pharmaceutical composition according to claim 1, comprising:
R2およびR3が水素であり;
YがSであり;
R1、L、およびXが請求項1における定義と同じである、式(I)で示される化合物またはその医薬上許容される塩、水和物、溶媒和物もしくはエステルを含む、請求項1記載の医薬組成物。 Z is NH;
R 2 and R 3 are hydrogen;
Y is S;
A compound of formula (I) or a pharmaceutically acceptable salt, hydrate, solvate or ester thereof, wherein R 1 , L and X are as defined in claim 1. The pharmaceutical composition as described.
XがOHであり;
Z、R1、R2、R3およびYが請求項1における定義と同じである、式(I)で示される化合物またはその医薬上許容される塩、水和物、溶媒和物もしくはエステルを含む、請求項1記載の医薬組成物。 3-biphenyl, 4-biphenyl or 1-N-, wherein L is substituted with 1 to 3 substituents selected from the group consisting of nitro, alkyl, substituted alkyl, Br, Cl, CF 3 and F Selected from phenylpyrazole;
X is OH;
A compound of formula (I) or a pharmaceutically acceptable salt, hydrate, solvate or ester thereof, wherein Z, R 1 , R 2 , R 3 and Y are as defined in claim 1; A pharmaceutical composition according to claim 1 comprising .
Xは、3−カルボン酸、4−カルボン酸、3−スルホン酸または4−スルホン酸から選択され;
Wは、ニトロ、アルキル、置換アルキル、Br、Cl、CF3およびFからなる群から選択される1〜3個の置換基で置換されている、3−フェニルまたは4−フェニルから選択される]
で示される化合物またはその医薬上許容される塩、水和物、溶媒和物もしくはエステルを含む、請求項1記載の医薬組成物。 Formula (II):
X is selected from 3-carboxylic acid, 4-carboxylic acid, 3-sulfonic acid or 4-sulfonic acid;
W is selected from 3-phenyl or 4-phenyl substituted with 1-3 substituents selected from the group consisting of nitro, alkyl, substituted alkyl, Br, Cl, CF 3 and F]
In the compound represented or a pharmaceutically acceptable salt, hydrate, solvate or ester, pharmaceutical composition of claim 1.
Wは、ニトロ、アルキル、置換アルキル、Br、Cl、CF3およびFからなる群から選択される1〜3個の置換基で置換されているN−フェニルである]
で示される化合物またはその医薬上許容される塩、水和物、溶媒和物もしくはエステルを含む、請求項1記載の医薬組成物。 Formula (III):
W is N-phenyl substituted with 1 to 3 substituents selected from the group consisting of nitro, alkyl, substituted alkyl, Br, Cl, CF 3 and F]
In the compound represented or a pharmaceutically acceptable salt, hydrate, solvate or ester, pharmaceutical composition of claim 1.
4−(4−クロロ−2−メチルフェニル)−1−(3,5−ジニトロ−2−ヒドロキシベンジリデン)−3−チオセミカルバジド;
1−(3,5−ジニトロ−2−ヒドロキシベンジリデン)−4−(2−メチルフェニル)−3−チオセミカルバジド;
1−(3,5−ジクロロ−2−ヒドロキシベンジリデン)−4−(4−エトキシカルボニルフェニル)−3−チオセミカルバジド;
4−(ナフタ−1−イル)−1−(2,4,6−トリヒドロキシベンジリデン)−3−チオセミカルバジド;
1−(3,5−ジクロロ−2−ヒドロキシベンジリデン)−4−(4−スルホフェニル)−3−チオセミカルバジド;
1−[(2−ヒドロキシナフタ−1−イル)メチリデン]−4−(4−スルホフェニル)−3−チオセミカルバジド;
4−(4−カルボキシフェニル)−1−(3,5−ジクロロ−2−ヒドロキシベンジリデン)−3−チオセミカルバジド;
1−[1−(4−カルボキシ−2−ヒドロキシフェニル)エチリデン]−4−(ナフタ−1−イル)−3−チオセミカルバジド;
4−(4−カルボキシフェニル)−1−[(2−ヒドロキシナフタ−1−イル)メチリデン]−3−チオセミカルバジド;
4−(3−カルボキシフェニル)−1−[(2−ヒドロキシナフタ−1−イル)メチリデン]−3−チオセミカルバジド;
4−(3−カルボキシフェニル)−1−(3,5−ジクロロ−2−ヒドロキシベンジリデン)−3−チオセミカルバジド;
1−(4−カルボキシ−2−ヒドロキシベンジリデン)−4−(ナフタ−1−イル)−3−チオセミカルバジド;
4−(4−カルボキシフェニル)−1−(3,5−ジブロモ−2−ヒドロキシベンジリデン)−3−チオセミカルバジド;
4−(3−カルボキシフェニル)−1−(3,5−ジブロモ−2−ヒドロキシベンジリデン)−3−チオセミカルバジド;
1−(4−ベンジルオキシ−2−ヒドロキシベンジリデン)−4−(4−カルボキシフェニル)−3−チオセミカルバジド;
1−(4−ベンジルオキシ−2−ヒドロキシベンジリデン)−4−(3−カルボキシフェニル)−3−チオセミカルバジド;
4−(3−カルボキシフェニル)−1−(5−クロロ−2−ヒドロキシベンジリデン)−3−チオセミカルバジド;
4−(4−カルボキシフェニル)−1−[(1−ヒドロキシナフタ−2−イル)メチリデン]−3−チオセミカルバジド;
4−(3−カルボキシフェニル)−1−[(1−ヒドロキシナフタ−2−イル)メチリデン]−3−チオセミカルバジド;
4−(4−カルボキシフェニル)−1−(3,5−ジ−t−ブチル−2−ヒドロキシベンジリデン)−3−チオセミカルバジド;
4−(3−カルボキシフェニル)−1−(3,5−ジ−t−ブチル−2−ヒドロキシベンジリデン)−3−チオセミカルバジド;
4−(4−カルボキシフェニル)−1−(2−ヒドロキシ−3−メチルベンジリデン)−3−チオセミカルバジド;
4−(3−カルボキシフェニル)−1−(2−ヒドロキシ−3−メチルベンジリデン)−3−チオセミカルバジド;
4−(3−カルボキシフェニル)−1−(2−ヒドロキシ−5−メチルベンジリデン)−3−チオセミカルバジド;
1−(2,4−ジヒドロキシベンジリデン)−4−(ナフタ−1−イル)−3−チオセミカルバジド;
1−(2−ヒドロキシ−3−カルボキシベンジリデン)−4−(2−フェニルフェニル)−3−チオセミカルバジド;
4−(3−クロロ−2−メチルフェニル)−1−(2−ヒドロキシ−4−カルボキシベンジリデン)−3−チオセミカルバジド;
1−(2−ヒドロキシ−4−カルボキシベンジリデン)−4−(2−フェニルフェニル)−3−チオセミカルバジド;
4−(3−クロロ−4−メチルフェニル)−1−(2−ヒドロキシ−4−カルボキシベンジリデン)−3−チオセミカルバジド;
1−(2−ヒドロキシ−4−カルボキシベンジリデン)−4−(4−メチルフェニル)−3−チオセミカルバジド;
4−(4−カルボキシフェニル)−1−[2−メトキシ−3−(4−メチルフェニル)ベンジリデン]−3−チオセミカルバジド;
4−(3−カルボキシフェニル)−1−[3−(4−フルオロフェニル)−2−メトキシベンジリデン]−3−チオセミカルバジド;
4−(4−カルボキシフェニル)−1−[3−(4−クロロフェニル)−2−メトキシベンジリデン]−3−チオセミカルバジド;
4−(3−カルボキシフェニル)−1−[3−(4−クロロフェニル)−2−メトキシベンジリデン]−3−チオセミカルバジド;
4−(4−カルボキシフェニル)−1−[3−(ジベンゾ[b,d]フラン−1−イル)−2−メトキシベンジリデン]−3−チオセミカルバジド;
4−(4−カルボキシフェニル)−1−[2−ヒドロキシ−3−(2−メチルフェニル)ベンジリデン]−3−チオセミカルバジド;
4−(3−カルボキシフェニル)−1−[2−ヒドロキシ−3−(2−メチルフェニル)ベンジリデン]−3−チオセミカルバジド;
4−(4−カルボキシフェニル)−1−[3−(3,4−ジメチルフェニル)−2−ヒドロキシベンジリデン]−3−チオセミカルバジド;
4−(3−カルボキシフェニル)−1−[3−(3,4−ジメチルフェニル)−2−ヒドロキシベンジリデン]−3−チオセミカルバジド;
4−(4−カルボキシフェニル)−1−[2−ヒドロキシ−3−(3−トリフルオロメチルフェニル)ベンジリデン]−3−チオセミカルバジド;
4−(3−カルボキシフェニル)−1−[2−ヒドロキシ−3−(3−トリフルオロメチルフェニル)ベンジリデン]−3−チオセミカルバジド;
4−(4−カルボキシフェニル)−1−[3−(4−フルオロフェニル)−2−ヒドロキシベンジリデン]−3−チオセミカルバジド;
4−(3−カルボキシフェニル)−1−[3−(4−クロロフェニル)−2−ヒドロキシベンジリデン]−3−チオセミカルバジド;
4−(4−カルボキシフェニル)−1−[3−(ジベンゾ[b,d]フラン−1−イル)−2−ヒドロキシベンジリデン]−3−チオセミカルバジド;
4−(3−カルボキシフェニル)−1−[3−(ジベンゾ[b,d]フラン−1−イル)−2−ヒドロキシベンジリデン]−3−チオセミカルバジド;
4−(4−カルボキシフェニル)−1−[2−ヒドロキシ−3−(ナフタ−1−イル)ベンジリデン]−3−チオセミカルバジド;
4−(3−カルボキシフェニル)−1−[2−ヒドロキシ−3−(ナフタ−1−イル)ベンジリデン]−3−チオセミカルバジド;
4−(4−カルボキシフェニル)−1−[3−(3−クロロフェニル)−2−ヒドロキシベンジリデン]−3−チオセミカルバジド;
4−(3−カルボキシフェニル)−1−[3−(3−クロロフェニル)−2−ヒドロキシベンジリデン]−3−チオセミカルバジド;
4−(4−カルボキシフェニル)−1−[2−ヒドロキシ−3−(3−ニトロフェニル)ベンジリデン]−3−チオセミカルバジド;
4−(3−カルボキシフェニル)−1−[2−ヒドロキシ−3−(3−ニトロフェニル)ベンジリデン]−3−チオセミカルバジド;
4−(4−カルボキシフェニル)−1−(2−ヒドロキシ−4−フェニルベンジリデン)−3−チオセミカルバジド;
4−(3−カルボキシフェニル)−1−(2−ヒドロキシ−4−フェニルベンジリデン)−3−チオセミカルバジド;
4−(4−カルボキシフェニル)−1−[{1−(4−クロロフェニル)−5−ヒドロキシ−3−メチルピラゾール−4−イル}メチレン]−3−チオセミカルバジド;
4−(3−カルボキシフェニル)−1−[{1−(4−クロロフェニル)−5−ヒドロキシ−3−メチルピラゾール−4−イル}メチレン]−3−チオセミカルバジド;
4−(4−カルボキシフェニル)−1−[(5−ヒドロキシ−3−メチル−1−フェニルピラゾール−4−イル)メチレン]−3−チオセミカルバジド;
4−(3−カルボキシフェニル)−1−[(5−ヒドロキシ−3−メチル−1−フェニルピラゾール−4−イル)メチレン]−3−チオセミカルバジド;
4−(4−カルボキシフェニル)−1−[{1−(3,4−ジメチルフェニル)−5−ヒドロキシ−3−メチルピラゾール−4−イル}メチレン]−3−チオセミカルバジド;
4−(3−カルボキシフェニル)−1−[{1−(3,4−ジメチルフェニル)−5−ヒドロキシ−3−メチルピラゾール−4−イル}メチレン]−3−チオセミカルバジド;
4−(4−カルボキシフェニル)−1−[{5−ヒドロキシ−3−メチル−1−(4−メチルフェニル)ピラゾール−4−イル}メチレン]−3−チオセミカルバジド;
4−(3−カルボキシフェニル)−1−[{5−ヒドロキシ−3−メチル−1−(4−メチルフェニル)ピラゾール−4−イル}メチレン]−3−チオセミカルバジド;
4−(4−カルボキシフェニル)−1−[{1−(3−クロロフェニル)−5−ヒドロキシ−3−メチルピラゾール−4−イル}メチレン]−3−チオセミカルバジド;および
4−(3−カルボキシフェニル)−1−[{1−(3−クロロフェニル)−5−ヒドロキシ−3−メチルピラゾール−4−イル}メチレン]−3−チオセミカルバジド。 The pharmaceutical composition according to claim 1 , wherein the compound is a compound selected from the following compounds and pharmaceutically acceptable salts, hydrates, solvates and esters thereof :
4- (4-chloro-2-methylphenyl) -1- (3,5-dinitro-2-hydroxybenzylidene) -3-thiosemicarbazide;
1- (3,5-dinitro-2-hydroxybenzylidene) -4- (2-methylphenyl) -3-thiosemicarbazide;
1- (3,5-dichloro-2-hydroxybenzylidene) -4- (4-ethoxycarbonylphenyl) -3-thiosemicarbazide;
4- (naphth-1-yl) -1- (2,4,6-trihydroxybenzylidene) -3-thiosemicarbazide;
1- (3,5-dichloro-2-hydroxybenzylidene) -4- (4-sulfophenyl) -3-thiosemicarbazide;
1-[(2-hydroxynaphth-1-yl) methylidene] -4- (4-sulfophenyl) -3-thiosemicarbazide;
4- (4-carboxyphenyl) -1- (3,5-dichloro-2-hydroxybenzylidene) -3-thiosemicarbazide;
1- [1- (4-carboxy-2-hydroxyphenyl) ethylidene] -4- (naphth-1-yl) -3-thiosemicarbazide;
4- (4-carboxyphenyl) -1-[(2-hydroxynaphth-1-yl) methylidene] -3-thiosemicarbazide;
4- (3-carboxyphenyl) -1-[(2-hydroxynaphth-1-yl) methylidene] -3-thiosemicarbazide;
4- (3-carboxyphenyl) -1- (3,5-dichloro-2-hydroxybenzylidene) -3-thiosemicarbazide;
1- (4-carboxy-2-hydroxybenzylidene) -4- (naphth-1-yl) -3-thiosemicarbazide;
4- (4-carboxyphenyl) -1- (3,5-dibromo-2-hydroxybenzylidene) -3-thiosemicarbazide;
4- (3-carboxyphenyl) -1- (3,5-dibromo-2-hydroxybenzylidene) -3-thiosemicarbazide;
1- (4-benzyloxy-2-hydroxybenzylidene) -4- (4-carboxyphenyl) -3-thiosemicarbazide;
1- (4-benzyloxy-2-hydroxybenzylidene) -4- (3-carboxyphenyl) -3-thiosemicarbazide;
4- (3-carboxyphenyl) -1- (5-chloro-2-hydroxybenzylidene) -3-thiosemicarbazide;
4- (4-carboxyphenyl) -1-[(1-hydroxynaphth-2-yl) methylidene] -3-thiosemicarbazide;
4- (3-carboxyphenyl) -1-[(1-hydroxynaphth-2-yl) methylidene] -3-thiosemicarbazide;
4- (4-carboxyphenyl) -1- (3,5-di-t-butyl-2-hydroxybenzylidene) -3-thiosemicarbazide;
4- (3-carboxyphenyl) -1- (3,5-di-t-butyl-2-hydroxybenzylidene) -3-thiosemicarbazide;
4- (4-carboxyphenyl) -1- (2-hydroxy-3-methylbenzylidene) -3-thiosemicarbazide;
4- (3-carboxyphenyl) -1- (2-hydroxy-3-methylbenzylidene) -3-thiosemicarbazide;
4- (3-carboxyphenyl) -1- (2-hydroxy-5-methylbenzylidene) -3-thiosemicarbazide;
1- (2,4-dihydroxybenzylidene) -4- (naphth-1-yl) -3-thiosemicarbazide;
1- (2-hydroxy-3-carboxybenzylidene) -4- (2-phenylphenyl) -3-thiosemicarbazide;
4- (3-chloro-2-methylphenyl) -1- (2-hydroxy-4-carboxybenzylidene) -3-thiosemicarbazide;
1- (2-hydroxy-4-carboxybenzylidene) -4- (2-phenylphenyl) -3-thiosemicarbazide;
4- (3-chloro-4-methylphenyl) -1- (2-hydroxy-4-carboxybenzylidene) -3-thiosemicarbazide;
1- (2-hydroxy-4-carboxybenzylidene) -4- (4-methylphenyl) -3-thiosemicarbazide;
4- (4-carboxyphenyl) -1- [2-methoxy-3- (4-methylphenyl) benzylidene] -3-thiosemicarbazide;
4- (3-carboxyphenyl) -1- [3- (4-fluorophenyl) -2-methoxybenzylidene] -3-thiosemicarbazide;
4- (4-carboxyphenyl) -1- [3- (4-chlorophenyl) -2-methoxybenzylidene] -3-thiosemicarbazide;
4- (3-carboxyphenyl) -1- [3- (4-chlorophenyl) -2-methoxybenzylidene] -3-thiosemicarbazide;
4- (4-carboxyphenyl) -1- [3- (dibenzo [b, d] furan-1-yl) -2-methoxybenzylidene] -3-thiosemicarbazide;
4- (4-carboxyphenyl) -1- [2-hydroxy-3- (2-methylphenyl) benzylidene] -3-thiosemicarbazide;
4- (3-carboxyphenyl) -1- [2-hydroxy-3- (2-methylphenyl) benzylidene] -3-thiosemicarbazide;
4- (4-carboxyphenyl) -1- [3- (3,4-dimethylphenyl) -2-hydroxybenzylidene] -3-thiosemicarbazide;
4- (3-carboxyphenyl) -1- [3- (3,4-dimethylphenyl) -2-hydroxybenzylidene] -3-thiosemicarbazide;
4- (4-carboxyphenyl) -1- [2-hydroxy-3- (3-trifluoromethylphenyl) benzylidene] -3-thiosemicarbazide;
4- (3-carboxyphenyl) -1- [2-hydroxy-3- (3-trifluoromethylphenyl) benzylidene] -3-thiosemicarbazide;
4- (4-carboxyphenyl) -1- [3- (4-fluorophenyl) -2-hydroxybenzylidene] -3-thiosemicarbazide;
4- (3-carboxyphenyl) -1- [3- (4-chlorophenyl) -2-hydroxybenzylidene] -3-thiosemicarbazide;
4- (4-carboxyphenyl) -1- [3- (dibenzo [b, d] furan-1-yl) -2-hydroxybenzylidene] -3-thiosemicarbazide;
4- (3-carboxyphenyl) -1- [3- (dibenzo [b, d] furan-1-yl) -2-hydroxybenzylidene] -3-thiosemicarbazide;
4- (4-carboxyphenyl) -1- [2-hydroxy-3- (naphth-1-yl) benzylidene] -3-thiosemicarbazide;
4- (3-carboxyphenyl) -1- [2-hydroxy-3- (naphth-1-yl) benzylidene] -3-thiosemicarbazide;
4- (4-carboxyphenyl) -1- [3- (3-chlorophenyl) -2-hydroxybenzylidene] -3-thiosemicarbazide;
4- (3-carboxyphenyl) -1- [3- (3-chlorophenyl) -2-hydroxybenzylidene] -3-thiosemicarbazide;
4- (4-carboxyphenyl) -1- [2-hydroxy-3- (3-nitrophenyl) benzylidene] -3-thiosemicarbazide;
4- (3-carboxyphenyl) -1- [2-hydroxy-3- (3-nitrophenyl) benzylidene] -3-thiosemicarbazide;
4- (4-carboxyphenyl) -1- (2-hydroxy-4-phenylbenzylidene) -3-thiosemicarbazide;
4- (3-carboxyphenyl) -1- (2-hydroxy-4-phenylbenzylidene) -3-thiosemicarbazide;
4- (4-carboxyphenyl) -1-[{1- (4-chlorophenyl) -5-hydroxy-3-methylpyrazol-4-yl} methylene] -3-thiosemicarbazide;
4- (3-carboxyphenyl) -1-[{1- (4-chlorophenyl) -5-hydroxy-3-methylpyrazol-4-yl} methylene] -3-thiosemicarbazide;
4- (4-carboxyphenyl) -1-[(5-hydroxy-3-methyl-1-phenylpyrazol-4-yl) methylene] -3-thiosemicarbazide;
4- (3-carboxyphenyl) -1-[(5-hydroxy-3-methyl-1-phenylpyrazol-4-yl) methylene] -3-thiosemicarbazide;
4- (4-carboxyphenyl) -1-[{1- (3,4-dimethylphenyl) -5-hydroxy-3-methylpyrazol-4-yl} methylene] -3-thiosemicarbazide;
4- (3-carboxyphenyl) -1-[{1- (3,4-dimethylphenyl) -5-hydroxy-3-methylpyrazol-4-yl} methylene] -3-thiosemicarbazide;
4- (4-carboxyphenyl) -1-[{5-hydroxy-3-methyl-1- (4-methylphenyl) pyrazol-4-yl} methylene] -3-thiosemicarbazide;
4- (3-carboxyphenyl) -1-[{5-hydroxy-3-methyl-1- (4-methylphenyl) pyrazol-4-yl} methylene] -3-thiosemicarbazide;
4- (4-carboxyphenyl) -1-[{1- (3-chlorophenyl) -5-hydroxy-3-methylpyrazol-4-yl} methylene] -3-thiosemicarbazide; and 4- (3-carboxyphenyl ) -1-[{1- (3-Chlorophenyl) -5-hydroxy-3-methylpyrazol-4-yl} methylene] -3-thiosemicarbazide.
4−(ナフタ−1−イル)−1−(2,4,6−トリヒドロキシベンジリデン)−3−チオセミカルバジド; 4- (naphth-1-yl) -1- (2,4,6-trihydroxybenzylidene) -3-thiosemicarbazide;
1−(3,5−ジクロロ−2−ヒドロキシベンジリデン)−4−(4−スルホフェニル)−3−チオセミカルバジド; 1- (3,5-dichloro-2-hydroxybenzylidene) -4- (4-sulfophenyl) -3-thiosemicarbazide;
1−[(2−ヒドロキシナフタ−1−イル)メチリデン]−4−(4−スルホフェニル)−3−チオセミカルバジド; 1-[(2-hydroxynaphth-1-yl) methylidene] -4- (4-sulfophenyl) -3-thiosemicarbazide;
4−(4−カルボキシフェニル)−1−(3,5−ジクロロ−2−ヒドロキシベンジリデン)−3−チオセミカルバジド; 4- (4-carboxyphenyl) -1- (3,5-dichloro-2-hydroxybenzylidene) -3-thiosemicarbazide;
1−[1−(4−カルボキシ−2−ヒドロキシフェニル)エチリデン]−4−(ナフタ−1−イル)−3−チオセミカルバジド; 1- [1- (4-carboxy-2-hydroxyphenyl) ethylidene] -4- (naphth-1-yl) -3-thiosemicarbazide;
4−(4−カルボキシフェニル)−1−[(2−ヒドロキシナフタ−1−イル)メチリデン]−3−チオセミカルバジド; 4- (4-carboxyphenyl) -1-[(2-hydroxynaphth-1-yl) methylidene] -3-thiosemicarbazide;
4−(3−カルボキシフェニル)−1−[(2−ヒドロキシナフタ−1−イル)メチリデン]−3−チオセミカルバジド; 4- (3-carboxyphenyl) -1-[(2-hydroxynaphth-1-yl) methylidene] -3-thiosemicarbazide;
4−(3−カルボキシフェニル)−1−(3,5−ジクロロ−2−ヒドロキシベンジリデン)−3−チオセミカルバジド; 4- (3-carboxyphenyl) -1- (3,5-dichloro-2-hydroxybenzylidene) -3-thiosemicarbazide;
1−(4−カルボキシ−2−ヒドロキシベンジリデン)−4−(ナフタ−1−イル)−3−チオセミカルバジド; 1- (4-carboxy-2-hydroxybenzylidene) -4- (naphth-1-yl) -3-thiosemicarbazide;
4−(4−カルボキシフェニル)−1−(3,5−ジブロモ−2−ヒドロキシベンジリデン)−3−チオセミカルバジド; 4- (4-carboxyphenyl) -1- (3,5-dibromo-2-hydroxybenzylidene) -3-thiosemicarbazide;
4−(3−カルボキシフェニル)−1−(3,5−ジブロモ−2−ヒドロキシベンジリデン)−3−チオセミカルバジド; 4- (3-carboxyphenyl) -1- (3,5-dibromo-2-hydroxybenzylidene) -3-thiosemicarbazide;
1−(4−ベンジルオキシ−2−ヒドロキシベンジリデン)−4−(4−カルボキシフェニル)−3−チオセミカルバジド; 1- (4-benzyloxy-2-hydroxybenzylidene) -4- (4-carboxyphenyl) -3-thiosemicarbazide;
1−(4−ベンジルオキシ−2−ヒドロキシベンジリデン)−4−(3−カルボキシフェニル)−3−チオセミカルバジド; 1- (4-benzyloxy-2-hydroxybenzylidene) -4- (3-carboxyphenyl) -3-thiosemicarbazide;
4−(3−カルボキシフェニル)−1−(5−クロロ−2−ヒドロキシベンジリデン)−3−チオセミカルバジド; 4- (3-carboxyphenyl) -1- (5-chloro-2-hydroxybenzylidene) -3-thiosemicarbazide;
4−(4−カルボキシフェニル)−1−[(1−ヒドロキシナフタ−2−イル)メチリデン]−3−チオセミカルバジド; 4- (4-carboxyphenyl) -1-[(1-hydroxynaphth-2-yl) methylidene] -3-thiosemicarbazide;
4−(3−カルボキシフェニル)−1−[(1−ヒドロキシナフタ−2−イル)メチリデン]−3−チオセミカルバジド; 4- (3-carboxyphenyl) -1-[(1-hydroxynaphth-2-yl) methylidene] -3-thiosemicarbazide;
4−(4−カルボキシフェニル)−1−(3,5−ジ−t−ブチル−2−ヒドロキシベンジリデン)−3−チオセミカルバジド; 4- (4-carboxyphenyl) -1- (3,5-di-t-butyl-2-hydroxybenzylidene) -3-thiosemicarbazide;
4−(3−カルボキシフェニル)−1−(3,5−ジ−t−ブチル−2−ヒドロキシベンジリデン)−3−チオセミカルバジド; 4- (3-carboxyphenyl) -1- (3,5-di-t-butyl-2-hydroxybenzylidene) -3-thiosemicarbazide;
4−(4−カルボキシフェニル)−1−(2−ヒドロキシ−3−メチルベンジリデン)−3−チオセミカルバジド; 4- (4-carboxyphenyl) -1- (2-hydroxy-3-methylbenzylidene) -3-thiosemicarbazide;
4−(3−カルボキシフェニル)−1−(2−ヒドロキシ−3−メチルベンジリデン)−3−チオセミカルバジド; 4- (3-carboxyphenyl) -1- (2-hydroxy-3-methylbenzylidene) -3-thiosemicarbazide;
4−(3−カルボキシフェニル)−1−(2−ヒドロキシ−5−メチルベンジリデン)−3−チオセミカルバジド; 4- (3-carboxyphenyl) -1- (2-hydroxy-5-methylbenzylidene) -3-thiosemicarbazide;
1−(2,4−ジヒドロキシベンジリデン)−4−(ナフタ−1−イル)−3−チオセミカルバジド; 1- (2,4-dihydroxybenzylidene) -4- (naphth-1-yl) -3-thiosemicarbazide;
1−(2−ヒドロキシ−3−カルボキシベンジリデン)−4−(2−フェニルフェニル)−3−チオセミカルバジド; 1- (2-hydroxy-3-carboxybenzylidene) -4- (2-phenylphenyl) -3-thiosemicarbazide;
4−(3−クロロ−2−メチルフェニル)−1−(2−ヒドロキシ−4−カルボキシベンジリデン)−3−チオセミカルバジド; 4- (3-chloro-2-methylphenyl) -1- (2-hydroxy-4-carboxybenzylidene) -3-thiosemicarbazide;
1−(2−ヒドロキシ−4−カルボキシベンジリデン)−4−(2−フェニルフェニル)−3−チオセミカルバジド; 1- (2-hydroxy-4-carboxybenzylidene) -4- (2-phenylphenyl) -3-thiosemicarbazide;
4−(3−クロロ−4−メチルフェニル)−1−(2−ヒドロキシ−4−カルボキシベンジリデン)−3−チオセミカルバジド; 4- (3-chloro-4-methylphenyl) -1- (2-hydroxy-4-carboxybenzylidene) -3-thiosemicarbazide;
1−(2−ヒドロキシ−4−カルボキシベンジリデン)−4−(4−メチルフェニル)−3−チオセミカルバジド; 1- (2-hydroxy-4-carboxybenzylidene) -4- (4-methylphenyl) -3-thiosemicarbazide;
4−(4−カルボキシフェニル)−1−[2−メトキシ−3−(4−メチルフェニル)ベンジリデン]−3−チオセミカルバジド; 4- (4-carboxyphenyl) -1- [2-methoxy-3- (4-methylphenyl) benzylidene] -3-thiosemicarbazide;
4−(3−カルボキシフェニル)−1−[3−(4−フルオロフェニル)−2−メトキシベンジリデン]−3−チオセミカルバジド; 4- (3-carboxyphenyl) -1- [3- (4-fluorophenyl) -2-methoxybenzylidene] -3-thiosemicarbazide;
4−(4−カルボキシフェニル)−1−[3−(4−クロロフェニル)−2−メトキシベンジリデン]−3−チオセミカルバジド; 4- (4-carboxyphenyl) -1- [3- (4-chlorophenyl) -2-methoxybenzylidene] -3-thiosemicarbazide;
4−(3−カルボキシフェニル)−1−[3−(4−クロロフェニル)−2−メトキシベンジリデン]−3−チオセミカルバジド; 4- (3-carboxyphenyl) -1- [3- (4-chlorophenyl) -2-methoxybenzylidene] -3-thiosemicarbazide;
4−(4−カルボキシフェニル)−1−[3−(ジベンゾ[b,d]フラン−1−イル)−2−メトキシベンジリデン]−3−チオセミカルバジド; 4- (4-carboxyphenyl) -1- [3- (dibenzo [b, d] furan-1-yl) -2-methoxybenzylidene] -3-thiosemicarbazide;
4−(4−カルボキシフェニル)−1−[2−ヒドロキシ−3−(2−メチルフェニル)ベンジリデン]−3−チオセミカルバジド; 4- (4-carboxyphenyl) -1- [2-hydroxy-3- (2-methylphenyl) benzylidene] -3-thiosemicarbazide;
4−(3−カルボキシフェニル)−1−[2−ヒドロキシ−3−(2−メチルフェニル)ベンジリデン]−3−チオセミカルバジド; 4- (3-carboxyphenyl) -1- [2-hydroxy-3- (2-methylphenyl) benzylidene] -3-thiosemicarbazide;
4−(4−カルボキシフェニル)−1−[3−(3,4−ジメチルフェニル)−2−ヒドロキシベンジリデン]−3−チオセミカルバジド; 4- (4-carboxyphenyl) -1- [3- (3,4-dimethylphenyl) -2-hydroxybenzylidene] -3-thiosemicarbazide;
4−(3−カルボキシフェニル)−1−[3−(3,4−ジメチルフェニル)−2−ヒドロキシベンジリデン]−3−チオセミカルバジド; 4- (3-carboxyphenyl) -1- [3- (3,4-dimethylphenyl) -2-hydroxybenzylidene] -3-thiosemicarbazide;
4−(4−カルボキシフェニル)−1−[2−ヒドロキシ−3−(3−トリフルオロメチルフェニル)ベンジリデン]−3−チオセミカルバジド; 4- (4-carboxyphenyl) -1- [2-hydroxy-3- (3-trifluoromethylphenyl) benzylidene] -3-thiosemicarbazide;
4−(3−カルボキシフェニル)−1−[2−ヒドロキシ−3−(3−トリフルオロメチルフェニル)ベンジリデン]−3−チオセミカルバジド; 4- (3-carboxyphenyl) -1- [2-hydroxy-3- (3-trifluoromethylphenyl) benzylidene] -3-thiosemicarbazide;
4−(4−カルボキシフェニル)−1−[3−(4−フルオロフェニル)−2−ヒドロキシベンジリデン]−3−チオセミカルバジド; 4- (4-carboxyphenyl) -1- [3- (4-fluorophenyl) -2-hydroxybenzylidene] -3-thiosemicarbazide;
4−(3−カルボキシフェニル)−1−[3−(4−クロロフェニル)−2−ヒドロキシベンジリデン]−3−チオセミカルバジド; 4- (3-carboxyphenyl) -1- [3- (4-chlorophenyl) -2-hydroxybenzylidene] -3-thiosemicarbazide;
4−(4−カルボキシフェニル)−1−[3−(ジベンゾ[b,d]フラン−1−イル)−2−ヒドロキシベンジリデン]−3−チオセミカルバジド; 4- (4-carboxyphenyl) -1- [3- (dibenzo [b, d] furan-1-yl) -2-hydroxybenzylidene] -3-thiosemicarbazide;
4−(3−カルボキシフェニル)−1−[3−(ジベンゾ[b,d]フラン−1−イル)−2−ヒドロキシベンジリデン]−3−チオセミカルバジド; 4- (3-carboxyphenyl) -1- [3- (dibenzo [b, d] furan-1-yl) -2-hydroxybenzylidene] -3-thiosemicarbazide;
4−(4−カルボキシフェニル)−1−[2−ヒドロキシ−3−(ナフタ−1−イル)ベンジリデン]−3−チオセミカルバジド; 4- (4-carboxyphenyl) -1- [2-hydroxy-3- (naphth-1-yl) benzylidene] -3-thiosemicarbazide;
4−(3−カルボキシフェニル)−1−[2−ヒドロキシ−3−(ナフタ−1−イル)ベンジリデン]−3−チオセミカルバジド; 4- (3-carboxyphenyl) -1- [2-hydroxy-3- (naphth-1-yl) benzylidene] -3-thiosemicarbazide;
4−(4−カルボキシフェニル)−1−[3−(3−クロロフェニル)−2−ヒドロキシベンジリデン]−3−チオセミカルバジド; 4- (4-carboxyphenyl) -1- [3- (3-chlorophenyl) -2-hydroxybenzylidene] -3-thiosemicarbazide;
4−(3−カルボキシフェニル)−1−[3−(3−クロロフェニル)−2−ヒドロキシベンジリデン]−3−チオセミカルバジド; 4- (3-carboxyphenyl) -1- [3- (3-chlorophenyl) -2-hydroxybenzylidene] -3-thiosemicarbazide;
4−(4−カルボキシフェニル)−1−[2−ヒドロキシ−3−(3−ニトロフェニル)ベンジリデン]−3−チオセミカルバジド; 4- (4-carboxyphenyl) -1- [2-hydroxy-3- (3-nitrophenyl) benzylidene] -3-thiosemicarbazide;
4−(3−カルボキシフェニル)−1−[2−ヒドロキシ−3−(3−ニトロフェニル)ベンジリデン]−3−チオセミカルバジド; 4- (3-carboxyphenyl) -1- [2-hydroxy-3- (3-nitrophenyl) benzylidene] -3-thiosemicarbazide;
4−(4−カルボキシフェニル)−1−(2−ヒドロキシ−4−フェニルベンジリデン)−3−チオセミカルバジド; 4- (4-carboxyphenyl) -1- (2-hydroxy-4-phenylbenzylidene) -3-thiosemicarbazide;
4−(3−カルボキシフェニル)−1−(2−ヒドロキシ−4−フェニルベンジリデン)−3−チオセミカルバジド; 4- (3-carboxyphenyl) -1- (2-hydroxy-4-phenylbenzylidene) -3-thiosemicarbazide;
4−(4−カルボキシフェニル)−1−[{1−(4−クロロフェニル)−5−ヒドロキシ−3−メチルピラゾール−4−イル}メチレン]−3−チオセミカルバジド; 4- (4-carboxyphenyl) -1-[{1- (4-chlorophenyl) -5-hydroxy-3-methylpyrazol-4-yl} methylene] -3-thiosemicarbazide;
4−(3−カルボキシフェニル)−1−[{1−(4−クロロフェニル)−5−ヒドロキシ−3−メチルピラゾール−4−イル}メチレン]−3−チオセミカルバジド; 4- (3-carboxyphenyl) -1-[{1- (4-chlorophenyl) -5-hydroxy-3-methylpyrazol-4-yl} methylene] -3-thiosemicarbazide;
4−(4−カルボキシフェニル)−1−[(5−ヒドロキシ−3−メチル−1−フェニルピラゾール−4−イル)メチレン]−3−チオセミカルバジド; 4- (4-carboxyphenyl) -1-[(5-hydroxy-3-methyl-1-phenylpyrazol-4-yl) methylene] -3-thiosemicarbazide;
4−(3−カルボキシフェニル)−1−[(5−ヒドロキシ−3−メチル−1−フェニルピラゾール−4−イル)メチレン]−3−チオセミカルバジド; 4- (3-carboxyphenyl) -1-[(5-hydroxy-3-methyl-1-phenylpyrazol-4-yl) methylene] -3-thiosemicarbazide;
4−(4−カルボキシフェニル)−1−[{1−(3,4−ジメチルフェニル)−5−ヒドロキシ−3−メチルピラゾール−4−イル}メチレン]−3−チオセミカルバジド; 4- (4-carboxyphenyl) -1-[{1- (3,4-dimethylphenyl) -5-hydroxy-3-methylpyrazol-4-yl} methylene] -3-thiosemicarbazide;
4−(3−カルボキシフェニル)−1−[{1−(3,4−ジメチルフェニル)−5−ヒドロキシ−3−メチルピラゾール−4−イル}メチレン]−3−チオセミカルバジド; 4- (3-carboxyphenyl) -1-[{1- (3,4-dimethylphenyl) -5-hydroxy-3-methylpyrazol-4-yl} methylene] -3-thiosemicarbazide;
4−(4−カルボキシフェニル)−1−[{5−ヒドロキシ−3−メチル−1−(4−メチルフェニル)ピラゾール−4−イル}メチレン]−3−チオセミカルバジド; 4- (4-carboxyphenyl) -1-[{5-hydroxy-3-methyl-1- (4-methylphenyl) pyrazol-4-yl} methylene] -3-thiosemicarbazide;
4−(3−カルボキシフェニル)−1−[{5−ヒドロキシ−3−メチル−1−(4−メチルフェニル)ピラゾール−4−イル}メチレン]−3−チオセミカルバジド; 4- (3-carboxyphenyl) -1-[{5-hydroxy-3-methyl-1- (4-methylphenyl) pyrazol-4-yl} methylene] -3-thiosemicarbazide;
4−(4−カルボキシフェニル)−1−[{1−(3−クロロフェニル)−5−ヒドロキシ−3−メチルピラゾール−4−イル}メチレン]−3−チオセミカルバジド;および 4- (4-carboxyphenyl) -1-[{1- (3-chlorophenyl) -5-hydroxy-3-methylpyrazol-4-yl} methylene] -3-thiosemicarbazide; and
4−(3−カルボキシフェニル)−1−[{1−(3−クロロフェニル)−5−ヒドロキシ−3−メチルピラゾール−4−イル}メチレン]−3−チオセミカルバジド。 4- (3-Carboxyphenyl) -1-[{1- (3-chlorophenyl) -5-hydroxy-3-methylpyrazol-4-yl} methylene] -3-thiosemicarbazide.
4−(4−カルボキシフェニル)−1−[3−(3,4−ジメチルフェニル)−2−ヒドロキシベンジリデン]−3−チオセミカルバジド; 4- (4-carboxyphenyl) -1- [3- (3,4-dimethylphenyl) -2-hydroxybenzylidene] -3-thiosemicarbazide;
4−(3−カルボキシフェニル)−1−[3−(3,4−ジメチルフェニル)−2−ヒドロキシベンジリデン]−3−チオセミカルバジド; 4- (3-carboxyphenyl) -1- [3- (3,4-dimethylphenyl) -2-hydroxybenzylidene] -3-thiosemicarbazide;
4−(4−カルボキシフェニル)−1−[2−ヒドロキシ−3−(3−トリフルオロメチルフェニル)ベンジリデン]−3−チオセミカルバジド; 4- (4-carboxyphenyl) -1- [2-hydroxy-3- (3-trifluoromethylphenyl) benzylidene] -3-thiosemicarbazide;
4−(3−カルボキシフェニル)−1−[2−ヒドロキシ−3−(3−トリフルオロメチルフェニル)ベンジリデン]−3−チオセミカルバジド; 4- (3-carboxyphenyl) -1- [2-hydroxy-3- (3-trifluoromethylphenyl) benzylidene] -3-thiosemicarbazide;
4−(4−カルボキシフェニル)−1−[3−(4−フルオロフェニル)−2−ヒドロキシベンジリデン]−3−チオセミカルバジド; 4- (4-carboxyphenyl) -1- [3- (4-fluorophenyl) -2-hydroxybenzylidene] -3-thiosemicarbazide;
4−(3−カルボキシフェニル)−1−[3−(4−クロロフェニル)−2−ヒドロキシベンジリデン]−3−チオセミカルバジド; 4- (3-carboxyphenyl) -1- [3- (4-chlorophenyl) -2-hydroxybenzylidene] -3-thiosemicarbazide;
4−(4−カルボキシフェニル)−1−[3−(ジベンゾ[b,d]フラン−1−イル)−2−ヒドロキシベンジリデン]−3−チオセミカルバジド; 4- (4-carboxyphenyl) -1- [3- (dibenzo [b, d] furan-1-yl) -2-hydroxybenzylidene] -3-thiosemicarbazide;
4−(4−カルボキシフェニル)−1−[2−ヒドロキシ−3−(ナフタ−1−イル)ベンジリデン]−3−チオセミカルバジド; 4- (4-carboxyphenyl) -1- [2-hydroxy-3- (naphth-1-yl) benzylidene] -3-thiosemicarbazide;
4−(3−カルボキシフェニル)−1−[2−ヒドロキシ−3−(ナフタ−1−イル)ベンジリデン]−3−チオセミカルバジド; 4- (3-carboxyphenyl) -1- [2-hydroxy-3- (naphth-1-yl) benzylidene] -3-thiosemicarbazide;
4−(4−カルボキシフェニル)−1−[3−(3−クロロフェニル)−2−ヒドロキシベンジリデン]−3−チオセミカルバジド; 4- (4-carboxyphenyl) -1- [3- (3-chlorophenyl) -2-hydroxybenzylidene] -3-thiosemicarbazide;
4−(3−カルボキシフェニル)−1−[3−(3−クロロフェニル)−2−ヒドロキシベンジリデン]−3−チオセミカルバジド; 4- (3-carboxyphenyl) -1- [3- (3-chlorophenyl) -2-hydroxybenzylidene] -3-thiosemicarbazide;
4−(4−カルボキシフェニル)−1−[{1−(3,4−ジメチルフェニル)−5−ヒドロキシ−3−メチルピラゾール−4−イル}メチレン]−3−チオセミカルバジド; 4- (4-carboxyphenyl) -1-[{1- (3,4-dimethylphenyl) -5-hydroxy-3-methylpyrazol-4-yl} methylene] -3-thiosemicarbazide;
4−(3−カルボキシフェニル)−1−[{1−(3,4−ジメチルフェニル)−5−ヒドロキシ−3−メチルピラゾール−4−イル}メチレン]−3−チオセミカルバジド; 4- (3-carboxyphenyl) -1-[{1- (3,4-dimethylphenyl) -5-hydroxy-3-methylpyrazol-4-yl} methylene] -3-thiosemicarbazide;
4−(4−カルボキシフェニル)−1−[{5−ヒドロキシ−3−メチル−1−(4−メチルフェニル)ピラゾール−4−イル}メチレン]−3−チオセミカルバジド; 4- (4-carboxyphenyl) -1-[{5-hydroxy-3-methyl-1- (4-methylphenyl) pyrazol-4-yl} methylene] -3-thiosemicarbazide;
4−(3−カルボキシフェニル)−1−[{5−ヒドロキシ−3−メチル−1−(4−メチルフェニル)ピラゾール−4−イル}メチレン]−3−チオセミカルバジド;および 4- (3-carboxyphenyl) -1-[{5-hydroxy-3-methyl-1- (4-methylphenyl) pyrazol-4-yl} methylene] -3-thiosemicarbazide; and
4−(4−カルボキシフェニル)−1−[{1−(3−クロロフェニル)−5−ヒドロキシ−3−メチルピラゾール−4−イル}メチレン]−3−チオセミカルバジド。 4- (4-Carboxyphenyl) -1-[{1- (3-chlorophenyl) -5-hydroxy-3-methylpyrazol-4-yl} methylene] -3-thiosemicarbazide.
4−(3−カルボキシフェニル)−1−[3−(3,4−ジメチルフェニル)−2−ヒドロキシベンジリデン]−3−チオセミカルバジド; 4- (3-carboxyphenyl) -1- [3- (3,4-dimethylphenyl) -2-hydroxybenzylidene] -3-thiosemicarbazide;
4−(4−カルボキシフェニル)−1−[2−ヒドロキシ−3−(3−トリフルオロメチルフェニル)ベンジリデン]−3−チオセミカルバジド; 4- (4-carboxyphenyl) -1- [2-hydroxy-3- (3-trifluoromethylphenyl) benzylidene] -3-thiosemicarbazide;
4−(3−カルボキシフェニル)−1−[2−ヒドロキシ−3−(3−トリフルオロメチルフェニル)ベンジリデン]−3−チオセミカルバジド;および 4- (3-carboxyphenyl) -1- [2-hydroxy-3- (3-trifluoromethylphenyl) benzylidene] -3-thiosemicarbazide; and
4−(3−カルボキシフェニル)−1−[3−(4−クロロフェニル)−2−ヒドロキシベンジリデン]−3−チオセミカルバジド。 4- (3-Carboxyphenyl) -1- [3- (4-chlorophenyl) -2-hydroxybenzylidene] -3-thiosemicarbazide.
4−(4−カルボキシフェニル)−1−[{5−ヒドロキシ−3−メチル−1−(4−メチルフェニル)ピラゾール−4−イル}メチレン]−3−チオセミカルバジド; 4- (4-carboxyphenyl) -1-[{5-hydroxy-3-methyl-1- (4-methylphenyl) pyrazol-4-yl} methylene] -3-thiosemicarbazide;
4−(3−カルボキシフェニル)−1−[{5−ヒドロキシ−3−メチル−1−(4−メチルフェニル)ピラゾール−4−イル}メチレン]−3−チオセミカルバジド;および 4- (3-carboxyphenyl) -1-[{5-hydroxy-3-methyl-1- (4-methylphenyl) pyrazol-4-yl} methylene] -3-thiosemicarbazide; and
4−(4−カルボキシフェニル)−1−[{1−(3−クロロフェニル)−5−ヒドロキシ−3−メチルピラゾール−4−イル}メチレン]−3−チオセミカルバジド。 4- (4-Carboxyphenyl) -1-[{1- (3-chlorophenyl) -5-hydroxy-3-methylpyrazol-4-yl} methylene] -3-thiosemicarbazide.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25662200P | 2000-12-19 | 2000-12-19 | |
PCT/US2001/050774 WO2002049413A2 (en) | 2000-12-19 | 2001-12-19 | Thrombopoietin mimetics |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2004520302A JP2004520302A (en) | 2004-07-08 |
JP2004520302A5 true JP2004520302A5 (en) | 2005-12-22 |
Family
ID=22972928
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2002550771A Pending JP2004520302A (en) | 2000-12-19 | 2001-12-19 | Thrombopoietin mimic |
Country Status (6)
Country | Link |
---|---|
US (1) | US7241783B2 (en) |
EP (1) | EP1349613A4 (en) |
JP (1) | JP2004520302A (en) |
AU (1) | AU2002239718A1 (en) |
CA (1) | CA2436288A1 (en) |
WO (1) | WO2002049413A2 (en) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CY2010012I2 (en) | 2000-05-25 | 2020-05-29 | Novartis Ag | THROMBOPOIETIN MIMETICS |
AUPS120902A0 (en) * | 2002-03-19 | 2002-04-18 | Unisearch Limited | Iron chelators as anti-proliferative agents against tumour cells |
AR040083A1 (en) | 2002-05-22 | 2005-03-16 | Smithkline Beecham Corp | BIS- (MONOETHANOLAMINE) ACID COMPOUND 3 '- [(2Z) - [1- (3,4-DIMETHYLPHENYL) -1,5-DIHIDRO-3-METHYL-5-OXO-4H-PIRAZOL-4-ILIDEN] HYDRAZINE ] -2'-HYDROXI- [1,1'-BIFENIL] -3-CARBOXILICO, PROCEDURE TO PREPARE IT, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT, PROCEDURE TO PREPARE SUCH FARMAC COMPOSITION |
US7851503B2 (en) | 2002-08-14 | 2010-12-14 | Nissan Chemical Industries, Ltd. | Thrombopoetin receptor activator and process for producing the same |
TWI324593B (en) * | 2002-10-09 | 2010-05-11 | Nissan Chemical Ind Ltd | Pyrazolone compounds and thrombopoietin receptor activator |
UA82695C2 (en) | 2003-06-06 | 2008-05-12 | Нисан Кемикал Индастриз, Лтд. | Heteroaromatic compounds as thrombopoietin receptor activators |
CN100443472C (en) * | 2003-06-06 | 2008-12-17 | 日产化学工业株式会社 | 3-alkylidenehydrazino substituted heteroaryl compounds as thrombopoietin receptor activators |
TW200526638A (en) | 2003-10-22 | 2005-08-16 | Smithkline Beecham Corp | 2-(3,4-dimethylphenyl)-4-{[2-hydroxy-3'-(1H-tetrazol-5-yl)biphenyl-3-yl]-hydrazono}-5-methyl-2,4-dihydropyrazol-3-one choline |
JP4716672B2 (en) * | 2004-05-19 | 2011-07-06 | 大塚製薬株式会社 | Megakaryocyte production inducer |
WO2005118551A2 (en) * | 2004-05-28 | 2005-12-15 | Ligand Pharmaceuticals Inc. | Thrombopoietin activity modulating compounds and methods |
MX2007004765A (en) * | 2004-10-25 | 2007-07-09 | Ligand Pharm Inc | Thrombopoietin activity modulating compounds and methods. |
TW200633998A (en) * | 2004-12-08 | 2006-10-01 | Nissan Chemical Ind Ltd | Substituted heterocyclic compounds and thrombopoietin receptor activators |
TW200633997A (en) * | 2004-12-08 | 2006-10-01 | Nissan Chemical Ind Ltd | Substituted heterocyclic compounds and thrombopoietin receptor activators |
EP1819692A1 (en) | 2004-12-08 | 2007-08-22 | Nissan Chemical Industries, Ltd. | 3-ethylidenehydrazino substituted heterocyclic compounds as thrombopoietin receptor activators |
EP1845090A4 (en) * | 2004-12-14 | 2009-11-11 | Nissan Chemical Ind Ltd | Amide compound and thrombopoietin receptor activator |
AU2006270801B2 (en) | 2005-07-15 | 2011-12-22 | Nissan Chemical Industries, Ltd. | Thiophene compounds and thrombopoietin receptor activators |
WO2007011056A1 (en) | 2005-07-20 | 2007-01-25 | Nissan Chemical Industries, Ltd. | Pyrazole compounds and thrombopoietin receptor activators |
JP5205967B2 (en) | 2005-11-07 | 2013-06-05 | 日産化学工業株式会社 | Hydrazide compounds and thrombopoietin receptor activators |
WO2007142308A1 (en) | 2006-06-07 | 2007-12-13 | Nissan Chemical Industries, Ltd. | Nitrogen-containing heterocyclic compound and thrombopoietin receptor activator |
ECSP077628A (en) | 2007-05-03 | 2008-12-30 | Smithkline Beechman Corp | NEW PHARMACEUTICAL COMPOSITION |
EP2225226B1 (en) | 2007-12-26 | 2016-08-17 | Critical Outcome Technologies, Inc. | Compounds and their use in a method for treatment of cancer |
CA2730890C (en) | 2008-07-17 | 2018-05-15 | Critical Outcome Technologies Inc. | Thiosemicarbazone inhibitor compounds and cancer treatment methods |
PE20100362A1 (en) | 2008-10-30 | 2010-05-27 | Irm Llc | PURINE DERIVATIVES THAT EXPAND HEMATOPOYETIC STEM CELLS |
US8680150B2 (en) * | 2009-05-28 | 2014-03-25 | Ligand Pharmaceuticals, Inc. | Small molecule hematopoietic growth factor mimetic compounds that activate hematopoietic growth factor receptors |
EP3127427B1 (en) | 2009-05-29 | 2020-01-08 | Novartis Ag | Methods of administration of thrombopoietin agonist compounds |
EP2492262B1 (en) * | 2009-10-23 | 2016-04-20 | Nissan Chemical Industries, Ltd. | Fused heterocyclic compound and thrombopoietin receptor activator |
EP3235818A3 (en) | 2010-04-01 | 2018-03-14 | Critical Outcome Technologies, Inc. | Compounds for the treatment of hiv |
UA109287C2 (en) * | 2010-11-02 | 2015-08-10 | ORGANIC AMIN SALTS OF THE AMINOBENSIC ACID DERIVATIVES AND THE METHOD OF PREPARATION thereof | |
WO2012102937A2 (en) | 2011-01-25 | 2012-08-02 | Irm Llc | Compounds that expand hematopoietic stem cells |
WO2013086436A1 (en) | 2011-12-08 | 2013-06-13 | Fred Hutchinson Cancer Research Center | Compositions and methods for enhanced generation of hematopoietic stem/progenitor cells |
WO2013110198A1 (en) | 2012-01-27 | 2013-08-01 | Université de Montréal | Pyrimido[4,5-b]indole derivatives and use thereof in the expansion of hematopoietic stem cells |
US10647718B2 (en) | 2014-04-22 | 2020-05-12 | Universitéde Montréal | Compounds and use thereof in the expansion of hematopoietic stem cells and/or hematopoietic progenitor cells |
JP6658535B2 (en) | 2014-10-31 | 2020-03-04 | 日産化学株式会社 | Ligand-bound fiber and cell culture substrate using the fiber |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE290184C (en) * | ||||
DE286580C (en) * | ||||
EP0433526A1 (en) * | 1989-12-19 | 1991-06-26 | Richter, Peter, Prof. Dr.sc.nat. | Medicine for the treatment of heart-circulatory illnesses, of arrhythmics in particular |
US5376451A (en) * | 1990-06-29 | 1994-12-27 | Minnesota Mining And Manufacturing Company | Yellow color-formers |
WO1999011262A1 (en) * | 1997-09-02 | 1999-03-11 | Roche Diagnostics Gmbh | Mpl-receptor ligands, process for their preparation, medicaments containing them and their use for the treatment and prevention of thrombocytopaenia and anaemia |
JP2002529502A (en) | 1998-11-17 | 2002-09-10 | スミスクライン・ビーチャム・コーポレイション | Treatment of thrombocytopenia |
EP1223944B1 (en) * | 1999-09-24 | 2007-01-03 | SmithKline Beecham Corporation | Thrombopoietin mimetics |
JP2003513965A (en) | 1999-11-05 | 2003-04-15 | スミスクライン・ビーチャム・コーポレイション | Semicarbazone derivatives and their use as thrombopoietin mimetics |
US6720345B1 (en) * | 1999-11-05 | 2004-04-13 | Smithkline Beecham Corporation | Semicarbazone derivatives and their use as thrombopoietin mimetics |
-
2001
- 2001-12-19 US US10/451,300 patent/US7241783B2/en not_active Expired - Fee Related
- 2001-12-19 JP JP2002550771A patent/JP2004520302A/en active Pending
- 2001-12-19 WO PCT/US2001/050774 patent/WO2002049413A2/en active Application Filing
- 2001-12-19 CA CA002436288A patent/CA2436288A1/en not_active Abandoned
- 2001-12-19 EP EP01987514A patent/EP1349613A4/en not_active Withdrawn
- 2001-12-19 AU AU2002239718A patent/AU2002239718A1/en not_active Abandoned
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2004520302A5 (en) | ||
US6235760B1 (en) | Treatment for CNS injuries | |
JP2005517666A5 (en) | ||
RU2000129161A (en) | DERIVATIVE 1 - [(1-SUBSTITUTED-4-PIPERIDINYL) METHYL] -4-PIPERIDINE, METHOD FOR ITS PRODUCTION, PHARMACEUTICAL COMPOSITION CONTAINING THE INDICATED COMPOUND, AND THE INTERMEDIATE PRODUCT | |
JP2003515560A5 (en) | ||
RU2002123350A (en) | Dipeptidnitrile Cathepsin K Inhibitors | |
JP2002515058A (en) | N-heterocyclic derivatives as NOS inhibitors | |
JP2009507011A5 (en) | ||
RU2007134383A (en) | DERIVATIVES OF 1,5-DIARILPYRROLA, THEIR PRODUCTION AND APPLICATION IN THERAPY | |
JP2002502874A5 (en) | ||
JP2004520302A (en) | Thrombopoietin mimic | |
RU2003134544A (en) | AMRIDES OF ANTRANILIC ACID, METHODS FOR PRODUCING THEM, THEIR APPLICATION AS ANTIARRHYTHMIC MEDICINES, AND ALSO CONTAINING THEIR PHARMACEUTICAL COMPOSITIONS | |
RS20060146A (en) | Malonamide derivatives blocking the activity of gama-secretase | |
RU2007127864A (en) | DERIVATIVES N - [(4, 5-DIPHENYL-3-ALKYL-2-THIENYL) METHYL] AMINE (AMIDE, SULFONAMIDE, CARBAMATE AND CARBAMIDE) AS AN ANTAGONISTS OF CB1 CANNABINOID RECEPTORS | |
RU2011127451A (en) | Thieno [3,2-c] Pyridine Derivatives as Kinase Inhibitors for Use in Cancer Treatment | |
JP2009542722A5 (en) | ||
JP2006507355A5 (en) | ||
CA2463102A1 (en) | Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors | |
JP2004517843A5 (en) | ||
JP2008519783A5 (en) | ||
JP2005529842A5 (en) | ||
RU96120211A (en) | APPLICATION OF DERIVATIVES IMIDAZOL FOR THE PREPARATION OF PHARMACEUTICAL ACTIVITIES FOR PLAYERS OF THE AT1 AND AT2 RECEPTORS ANGIOTENZINE, SOME OF THESE COMPOUNDS, A METHOD OF OBTAINING DERIVATIVES OF IMODASOL AND IMMODIMAHMAH OF AGROGRAM OF APPLICATIONS; | |
ATE429429T1 (en) | PHARMACEUTICAL PROCESS AND COMPOUNDS PRODUCED THEREFROM | |
JP2004507527A5 (en) | ||
JP2003502367A5 (en) |